Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/28/2008CA2275167C The topical use of kappa opioid agonists to treat ocular pain
10/28/2008CA2262791C Amino acid ester containing azole antifungals
10/28/2008CA2235318C Method for fighting against myases affecting cattle and sheep populations and compositions for implementing same
10/28/2008CA2232222C Treatment of hiv positive patients
10/28/2008CA2203456C Topical analgesic composition
10/28/2008CA2200568C Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof
10/28/2008CA2170748C Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
10/25/2008CA2835910A1 Improved vitamin d content uniformity in pharmaceutical dosage forms
10/25/2008CA2587805A1 Improved vitamin d content uniformity in pharmaceutical dosage forms
10/23/2008WO2008128193A1 Biodegradable polyanhydrides with natural bioactive molecules
10/23/2008WO2008128191A2 Oral cephalotaxine dosage forms
10/23/2008WO2008128189A1 Anti-cancer compositions and methods
10/23/2008WO2008128179A1 Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
10/23/2008WO2008128170A1 Methods for treating neoplasia with combination of chemotherapeutic agents and radiation
10/23/2008WO2008128169A1 Sparc and methods of use thereof
10/23/2008WO2008128166A1 Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
10/23/2008WO2008128129A1 Halo-stilbene derivatives and their use for binding and imaging of amyloid plaques
10/23/2008WO2008128126A1 Compositions and methods for prophylaxis and treatment of addictions
10/23/2008WO2008128121A1 Smac mimetic dimers and trimers useful as anti-cancer agents
10/23/2008WO2008128115A2 Low-dose doxepin formulations
10/23/2008WO2008128106A1 Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
10/23/2008WO2008128095A1 Ischemia/reperfusion protection compositions and methods of using
10/23/2008WO2008128086A1 Ranolazine for enhancing insulin secretion
10/23/2008WO2008128072A2 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
10/23/2008WO2008128064A2 Truncated analogs of peptide and polypeptide therapeutics
10/23/2008WO2008128063A1 Hydroquinone ansamycin formulations
10/23/2008WO2008128049A2 Tetrahydrobiopterin compositions and methods of measuring
10/23/2008WO2008128045A1 Solid forms of (e) -1- (4- ( (1r, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl)ethanone oxime
10/23/2008WO2008128028A2 Solifenacin compositions
10/23/2008WO2008128009A2 Aminopyrimidines useful as kinase inhibitors
10/23/2008WO2008127996A1 Methods and compositions for contributing to the treatment of cancers
10/23/2008WO2008127995A1 Nitric oxide releasing compounds
10/23/2008WO2008127975A2 Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008WO2008127924A1 Novel compounds
10/23/2008WO2008127893A1 Niacin-based pharmaceutical compositions
10/23/2008WO2008127813A1 Hibernation-related genes and proteins, activators and inhibitors thereof and methods of use
10/23/2008WO2008127728A1 Biaryl compositions and methods for modulating a kinase cascade
10/23/2008WO2008127727A1 Biaryl compositions and methods for modulating a kinase cascade
10/23/2008WO2008127725A1 Compositions and methods for treatment of psychiatric disorders
10/23/2008WO2008127722A1 Methods for treating spinal muscular atrophy using tetracycline compounds
10/23/2008WO2008127717A1 Selective androgen receptor modulators for treating diabetes
10/23/2008WO2008127715A1 Carboline derivatives useful in the treatment of cancer and other diseases
10/23/2008WO2008127714A1 Administration of carboline derivatives useful in the treatment of cancer and other diseases
10/23/2008WO2008127712A1 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
10/23/2008WO2008127710A2 Methods for treating cancer resistant to erbb therapeutics
10/23/2008WO2008127682A2 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
10/23/2008WO2008127679A1 Lyophilized pharmaceutical compositions and methods of making and using same
10/23/2008WO2008127678A1 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
10/23/2008WO2008127669A1 Bilayer lyophilized pharmaceutical compositions and methods of making and using same
10/23/2008WO2008127659A2 Anticancer combination of a dac inhibitor and a tyrosine kinase inhibitor
10/23/2008WO2008127654A2 Methods and compositions for intra-articular coagulation proteins
10/23/2008WO2008127650A1 Naturally-derived emulsifier system
10/23/2008WO2008127647A2 Antagonists of the transient receptor potential vanilloid 1 and uses thereof
10/23/2008WO2008127640A2 Substituted benzimidazoles
10/23/2008WO2008127618A1 Crystalline and amorphous forms of naltrexone hydrochloride
10/23/2008WO2008127615A1 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/23/2008WO2008127609A1 Melatonin tablet and methods of preparation and use
10/23/2008WO2008127605A1 Pharmaceutical compositions comprising calcitonin and an aromatase inhibitor
10/23/2008WO2008127603A2 Transient receptor potential vanilloid 1 and uses thereof
10/23/2008WO2008127594A2 Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer
10/23/2008WO2008127591A2 Pyrimidinedione derivatives and use thereof
10/23/2008WO2008127585A1 Substituted furo[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
10/23/2008WO2008127584A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups
10/23/2008WO2008127560A1 Process for making galantamine
10/23/2008WO2008127464A1 Heterocyclic compounds and their methods of use
10/23/2008WO2008127459A1 Pharmacological treatment of psoriasis
10/23/2008WO2008127456A2 Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
10/23/2008WO2008127419A2 Compositions and methods to increase the effect of a neurotoxin treatment
10/23/2008WO2008127381A2 Artemisinin derivatives
10/23/2008WO2008127303A1 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
10/23/2008WO2008127300A2 Oxazolidinone derivatives and methods of use
10/23/2008WO2008127275A2 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
10/23/2008WO2008127223A1 Cyclopropanes with central nervous system activity
10/23/2008WO2008127199A1 Methods of controlling tumorigenesis and diagnosing the risk thereof
10/23/2008WO2008127188A1 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/23/2008WO2008127138A1 Composition for decelerating the ageing in the organism and for extending the life time thereof and the use of said composition
10/23/2008WO2008127100A1 Means and methods for counteracting protein aggregation
10/23/2008WO2008127078A1 Anti-cancer agent comprising 4-hexadecanoyl-1,1-dimethyl-piperazin-1-ium iodide
10/23/2008WO2008127060A1 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
10/23/2008WO2008126980A1 Pharmaceutical composition for wound healing containing anthocyanin extracted from the black soybean seed coat
10/23/2008WO2008126979A1 Pharmaceutical composition for the prevention and treatment of the ischemia-reperfusion injury in the flaps or tissues containing anthocyanin extracted from the black soybean seed coat
10/23/2008WO2008126974A1 Composition for preventing and treating osseous metabolic disease
10/23/2008WO2008126943A2 Method for manufacturing neuraminic acid derivatives
10/23/2008WO2008126932A2 Epigenetical regulation of brain plasticity
10/23/2008WO2008126918A1 Twelve-membered cyclomacrolactam derivative
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008WO2008126898A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008WO2008126886A1 Indole or indoline derivative
10/23/2008WO2008126846A1 Antibacterial agent for vancomycin-resistant gram-positive bacterium
10/23/2008WO2008126831A1 Atropisomer of pyrrole derivative
10/23/2008WO2008126803A1 Ophthalmic composition comprising soluble, cross-linked hyaluronic acid
10/23/2008WO2008126797A1 Method for producing pulverized organic compound particle
10/23/2008WO2008126782A1 Antiseptic agent for skin
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008126756A1 Seleniferous compound and, containing the same, plant and nutritional supplement
10/23/2008WO2008126752A1 Skin-lightening agent containing equol compound as active ingredient
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008126731A1 Aryl derivatives
10/23/2008WO2008126720A1 Suspension for visualization of transparent tissue in eye
1 ... 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 ... 7860